- Home
- BTMD vs SEER Comparison
BTMD vs SEER Comparison
Compare BTMD & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTMD | SEER |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.6M | 98.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BTMD | SEER |
|---|---|---|
| Price | $2.58 | $1.91 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 132.4K | ★ 179.8K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 270.48 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $195,645,000.00 | $16,376,999.00 |
| Revenue This Year | N/A | $22.37 |
| Revenue Next Year | $2.80 | $30.00 |
| P/E Ratio | $3.47 | ★ N/A |
| Revenue Growth | 1.34 | ★ 12.11 |
| 52 Week Low | $2.32 | $1.62 |
| 52 Week High | $6.70 | $2.52 |
Technical Indicators
Market Signals| Indicator | BTMD | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 45.43 |
| Support Level | $2.32 | $1.76 |
| Resistance Level | $2.90 | $2.02 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 18.29 | 56.86 |
Price Performance
Historical ComparisonAbout BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.